RxDoctor Payments Data

Amy Stinson

Acute Care · Shreveport, LANPI 1194133421

Payments from drug & device makers

$595in general payments, 2019–2025

Across 28 payments — averaging $21.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$177
  • Pfizer$50
  • Lilly USA, LLC$48
  • Daiichi Sankyo Inc.$43
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$43
  • Takeda Pharmaceuticals U.S.A., Inc.$38
  • plus $196 from 10 others

What the payments were for

  • Food & beverage$55994%
  • Education$376%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$595 in reported general payments places this provider in the 50th percentile of 248 acute care providers in Louisiana.

See all acute care providers in Louisiana

Medicare billing

Part B allowed, 2024
$4,678
Medicare patients
27
Services billed
73

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other acute care in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →